Biomarker panel for early detection of endometrial cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

被引：2
|
作者：
Tarney, C. M. [1 ]
Wang, G. [1 ]
Bateman, N. W. [1 ]
Conrads, K. A. [1 ]
Zhou, M. [1 ]
Hood, B. L. [1 ]
Loffredo, J. [1 ]
Tian, C. [1 ]
Darcy, K. M. [1 ]
Lokshin, A. [2 ]
Hamilton, C. A. [3 ]
Casablanca, Y. [1 ]
Maxwell, G. L. [4 ]
Conrads, T. P. [5 ]
机构：
[1] Uniformed Serv Univ Hlth Sci, Gynecol Canc Ctr Excellence, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Inova Fairfax Hosp, Dept Obstet & Gynecol, Falls Church, VA USA
[5] Inova Schar Canc Inst, Fairfax, VA USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1101
引用
收藏
页码：42 / 43
页数：3
相关论文
共 50 条
  • [31] Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Jiaqi Huang
    Alison M Mondul
    Stephanie J Weinstein
    Stella Koutros
    Andriy Derkach
    Edward Karoly
    Joshua N Sampson
    Steven C Moore
    Sonja I Berndt
    Demetrius Albanes
    British Journal of Cancer, 2016, 115 : 1087 - 1095
  • [32] Lung Cancer Risk Following Detection of Pulmonary Scarring by Chest Radiography in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Yu, Ying-Ying
    Pinsky, Paul F.
    Caporaso, Neil E.
    Chatterjee, Nilanjan
    Baumgarten, Mona
    Langenberg, Patricia
    Furuno, Jon P.
    Lan, Qing
    Engels, Eric A.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (21) : 2326 - 2332
  • [33] Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation
    Tammemagi, C. Martin
    Pinsky, Paul F.
    Caporaso, Neil E.
    Kvale, Paul A.
    Hocking, William G.
    Church, Timothy R.
    Riley, Thomas L.
    Commins, John
    Oken, Martin M.
    Berg, Christine D.
    Prorok, Philip C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (13): : 1058 - 1068
  • [34] Effect of screening on ovarian cancer mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer randomized screening trial.
    Buys, S. S.
    Partridge, E.
    Black, A.
    Johnson, C.
    Lamerato, L.
    Isaacs, C.
    Reding, D.
    Greenlee, R.
    Kessel, B.
    Fouad, M.
    Chia, D.
    Ragard, L.
    Rathmell, J.
    Hartge, P.
    Pinsky, P.
    Izmirlian, G.
    Xu, J.
    Prorok, P.
    Berg, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    Buys, Saundra S.
    Partridge, Edward
    Black, Amanda
    Johnson, Christine C.
    Lamerato, Lois
    Isaacs, Claudine
    Reding, Douglas J.
    Greenlee, Robert T.
    Yokochi, Lance A.
    Kessel, Bruce
    Crawford, E. David
    Church, Timothy R.
    Andriole, Gerald L.
    Weissfeld, Joel L.
    Fouad, Mona N.
    Chia, David
    O'Brien, Barbara
    Ragard, Lawrence R.
    Clapp, Jonathan D.
    Rathmell, Joshua M.
    Riley, Thomas L.
    Hartge, Patricia
    Pinsky, Paul F.
    Zhu, Claire S.
    Izmirlian, Grant
    Kramer, Barnett S.
    Miller, Anthony B.
    Xu, Jian-Lun
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2295 - 2303
  • [36] Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
    Pejovic, Tanja
    Nezhat, Farr
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2011, 18 (06) : 823 - 825
  • [37] ESTIMATING THE COST FOR PROSTATE CANCER (PCA) SCREENING USING THE PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL DATA
    Crawford, D.
    Qureshi, Z.
    Mittmann, N.
    Kattan, M.
    Dickson, M.
    Andriole, G. L.
    Reding, D.
    Bennett, C.
    VALUE IN HEALTH, 2013, 16 (03) : A151 - A151
  • [38] Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Results from 4 years of annual screening in a randomized trial
    Partridge, Edward E.
    Kreimer, Aimee R.
    Buys, Saundra S.
    Reding, Douglas J.
    Fouad, Mona N.
    Riley, Thomas L.
    Greenlee, Robert T.
    Williams, Craig
    Prorok, Philip C.
    Xu, Jian-Lun
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S14 - S15
  • [39] Prostate cancer screening in the prostate, lung, colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial
    Andriole, GL
    Levin, DL
    Crawford, ED
    Gelmann, ER
    Pinsky, PF
    Chia, D
    Kramer, BS
    Reding, D
    Church, TR
    Grubb, RL
    Izmirlian, G
    Ragard, LR
    Clapp, JD
    Prorok, PC
    Gohagan, JK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 433 - 438
  • [40] Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial
    Buys, SS
    Partridge, E
    Greene, MH
    Prorok, PC
    Reding, D
    Riley, TL
    Hartge, P
    Fagerstrom, RM
    Chia, D
    Izmirlian, G
    Fouad, M
    Ragard, LR
    Johnson, CC
    Gohagan, JK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1630 - 1639
12345